242 related articles for article (PubMed ID: 29656749)
1. Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms.
Hegab AE; Ozaki M; Kagawa S; Hamamoto J; Yasuda H; Naoki K; Soejima K; Yin Y; Kinoshita T; Yaguchi T; Kawakami Y; Ornitz DM; Betsuyaku T
Lung Cancer; 2018 May; 119():25-35. PubMed ID: 29656749
[TBL] [Abstract][Full Text] [Related]
2. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma.
Arai D; Hegab AE; Soejima K; Kuroda A; Ishioka K; Yasuda H; Naoki K; Shizuko K; Hamamoto J; Yin Y; Ornitz DM; Betsuyaku T
J Pathol; 2015 Mar; 235(4):593-605. PubMed ID: 25413587
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
Zhang Y; Du W; Chen Z; Xiang C
Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation.
Wang A; Lu C; Ning Z; Gao W; Xie Y; Zhang N; Liang J; Abbasi FS; Yan Q; Liu J
Oncotarget; 2017 Apr; 8(17):28247-28259. PubMed ID: 28423676
[TBL] [Abstract][Full Text] [Related]
6. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
[TBL] [Abstract][Full Text] [Related]
7. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
8. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
9. Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3.
Yin Y; Betsuyaku T; Garbow JR; Miao J; Govindan R; Ornitz DM
Cancer Res; 2013 Sep; 73(18):5730-41. PubMed ID: 23867472
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody.
Yin Y; Ren X; Smith C; Guo Q; Malabunga M; Guernah I; Zhang Y; Shen J; Sun H; Chehab N; Loizos N; Ludwig DL; Ornitz DM
Dis Model Mech; 2016 May; 9(5):563-71. PubMed ID: 27056048
[TBL] [Abstract][Full Text] [Related]
11. Stromal PD-1
Chen L; Cao MF; Xiao JF; Ma QH; Zhang H; Cai RL; Miao JY; Wang WY; Zhang H; Luo M; Ping YF; Yao XH; Cui YH; Zhang X; Bian XW
Hum Pathol; 2020 Mar; 97():68-79. PubMed ID: 31926212
[TBL] [Abstract][Full Text] [Related]
12. Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages.
Wang DH; Lee HS; Yoon D; Berry G; Wheeler TM; Sugarbaker DJ; Kheradmand F; Engleman E; Burt BM
Clin Cancer Res; 2017 Feb; 23(3):778-788. PubMed ID: 27496865
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression.
Wang P; Xu LJ; Qin JJ; Zhang L; Zhuang GH
Biochem Biophys Res Commun; 2018 Sep; 503(2):452-458. PubMed ID: 29660336
[TBL] [Abstract][Full Text] [Related]
14. The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation.
Iriki T; Ohnishi K; Fujiwara Y; Horlad H; Saito Y; Pan C; Ikeda K; Mori T; Suzuki M; Ichiyasu H; Kohrogi H; Takeya M; Komohara Y
Lung Cancer; 2017 Apr; 106():22-32. PubMed ID: 28285690
[TBL] [Abstract][Full Text] [Related]
15. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
[TBL] [Abstract][Full Text] [Related]
16. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
17. The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis.
Li GG; Guo ZZ; Ma XF; Cao N; Geng SN; Zheng YQ; Meng MJ; Lin HH; Han G; Du GJ
Dev Comp Immunol; 2016 Jun; 59():89-98. PubMed ID: 26806760
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma.
Yin JZ; Shi XQ; Wang MD; Du H; Zhao XW; Li B; Yang MH
Int Immunopharmacol; 2023 Apr; 117():109899. PubMed ID: 36827926
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-activated alveolar macrophages having cytotoxicity toward lung tumor cells through cell-to-cell binding-dependent mechanism.
Taniguchi H; Shimada Y; Sawachi K; Hirota K; Inagawa H; Kohchi C; Soma G; Makino K; Terada H
Anticancer Res; 2010 Aug; 30(8):3159-65. PubMed ID: 20871035
[TBL] [Abstract][Full Text] [Related]
20. Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.
Ohgino K; Soejima K; Yasuda H; Hayashi Y; Hamamoto J; Naoki K; Arai D; Ishioka K; Sato T; Terai H; Ikemura S; Yoda S; Tani T; Kuroda A; Betsuyaku T
Lung Cancer; 2014 Jan; 83(1):90-6. PubMed ID: 24239165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
